NEW YORK (GenomeWeb) – Luminex said today that the US Food and Drug Administration has granted 510(k) clearance for its Aries Group A Strep Assay, a moderate complexity, sample-to-answer test for the direct detection of Streptococcus pyogenes from throat swab specimens using the Aries System.

The firm noted that it is the sixth assay that the FDA has cleared for use on its Aries systems in the last 24 months.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.